Biobanking Market Analysis

Specimen Type (Blood Products, Human Tissue, Nucleic Acids, Cell Lines, Biological Fluids)

The global biobanking market is segmented and analyzed for demand and supply by specimen type into blood products, human tissue, nucleic acids, cell lines, biological fluids, and others. Out of these sub-segments, the blood products segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising demand for the collection of specimens of blood products, the radically increasing the ratio of accidents, and the potentially growing prevalence of several types of hematological disorders across the globe.  For instance, in the United States, one person is diagnosed with leukemia, lymphoma, or myeloma every 4 minutes. Furthermore, in the United States, approximately 189,500 individuals were anticipated to be diagnosed with leukemia, lymphoma, or myeloma in 2021. Furthermore, blood products improve maternal health and child mortality and save millions of lives. 

Application (Regenerative Medicine, Life Science Research, Clinical Research)

The global biobanking market is also segmented and analyzed for demand and supply by application into regenerative medicine, life science research, and clinical research. Amongst these segments, the clinical research segment is expected to garner a significant share. In clinical research, biobanking is used for the systematic collection of data on a large scale and tissues for additional research purposes. Clinical research can last for an uncertain period, where biobanks become useful to preserve specimens with 100% quality for a prolonged time. For instance, in FY 2020, the National Institutes of Health were estimated to fund approximately USD 16 billion for clinical research in the United States.

Our in-depth analysis of the global market includes the following segments: